Induction of endotoxin tolerance inhibits alloimmune responses

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 158-165

  Ishiyama, Kohei ^a   Ohdan, Hideki ^a   Tokita, Daisuke ^a   Shishida, Masayuki ^a   Tanaka, Yuka ^a   Irei, Toshimitsu ^a   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Alloimmune response; Endotoxin tolerance; Mixed lymphocyte reaction; Transplantation

Indexed keywords

CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IRRADIATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL TIME; TH1 CELL; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; ENDOTOXINS; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION, HOMOLOGOUS;

EID: 33751420371     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.06.002     Document Type: Article

References (26)

1. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8 2 (1994) 217-225
2. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141 7 (1988) 2407-2412
3. Brooke M.S. Conversion of immunological paralysis to immunity by endotoxin. Nature 206 984 (1965) 635-636
4. Greisman S.E., Young E.J., Workman J.B., Ollodart R.M., and Hornick R.B. Mechanisms of endotoxin tolerance. The role of the spleen. J Clin Invest 56 6 (1975) 1597-1607
5. Chae B.S. Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin. Arch Pharm Res 25 6 (2002) 910-916
6. Hirohashi N., and Morrison D.C. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun 64 3 (1996) 1011-1015
7. Wolk K., Docke W.D., von Baehr V., Volk H.D., and Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96 1 (2000) 218-223
8. Ziegler-Heitbrock H.W. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45 1 (1995) 13-26
9. Cohen N., Morisset J., and Emilie D. Induction of tolerance by Porphyromonas gingivalis on APCS: a mechanism implicated in periodontal infection. J Dent Res 83 5 (2004) 429-433
10. Heemann U., Szabo A., Hamar P., Muller V., Witzke O., Lutz J., et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am J Pathol 156 1 (2000) 287-293
11. Dominguez F.E., Siemers F., Flohe S., Nau M., and Schade F.U. Effects of endotoxin tolerance on liver function after hepatic ischemia/reperfusion injury in the rat. Crit Care Med 30 1 (2002) 165-170
12. Toyoda T., Kassell N.F., and Lee K.S. Induction of tolerance against ischemia/reperfusion injury in the rat brain by preconditioning with the endotoxin analog diphosphoryl lipid A. J Neurosurg 92 3 (2000) 435-441
13. Kiani A., Tschiersch A., Gaboriau E., Otto F., Seiz A., Knopf H.P., et al. Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients. Blood 90 4 (1997) 1673-1683
14. Tanaka Y., Ohdan H., Onoe T., and Asahara T. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol Invest 33 3 (2004) 309-324
15. Ohdan H., Yang Y.G., Shimizu A., Swenson K.G., and Sykes M. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3 Gal-mediated graft rejection. J Clin Invest 104 3 (1999) 281-290
16. Pulendran B., Lingappa J., Kennedy M.K., Smith J., Teepe M., Rudensky A., et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol 159 5 (1997) 2222-2231
17. Maraskovsky E., Brasel K., Teepe M., Roux E.R., Lyman S.D., Shortman K., et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 184 5 (1996) 1953-1962
18. Boshell M., McLeod J., Walker L., Hall N., Patel Y., and Sansom D. Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells. Immunology 87 4 (1996) 586-592
19. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96 3 (1999) 1036-1041
20. Roake J.A., Rao A.S., Morris P.J., Larsen C.P., Hankins D.F., and Austyn J.M. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181 6 (1995) 2237-2247
21. Caldwell S., Heitger A., Shen W., Liu Y., Taylor B., and Ladisch S. Mechanisms of ganglioside inhibition of APC function. J Immunol 171 4 (2003) 1676-1683
22. Neurath M.F., Becker C., and Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43 6 (1998) 856-860
23. Wolk K., Kunz S., Crompton N.E., Volk H.D., and Sabat R. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem 278 20 (2003) 18030-18036
24. Patel D.R., Kaplan M.H., and Chang C.H. Altered Th1 cell differentiation programming by CIITA deficiency. J Immunol 173 9 (2004) 5501-5508
25. Lu L., Qian S., Hershberger P.A., Rudert W.A., Lynch D.H., and Thomson A.W. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 158 12 (1997) 5676-5684
26. Kronin V., Vremec D., Winkel K., Classon B.J., Miller R.G., Mak T.W., et al. Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int Immunol 9 7 (1997) 1061-1064